Targeting the SAGA and ATAC Transcriptional Coactivator Complexes in MYC-Driven Cancers

©2020 American Association for Cancer Research..

Targeting epigenetic regulators, such as histone-modifying enzymes, provides novel strategies for cancer therapy. The GCN5 lysine acetyltransferase (KAT) functions together with MYC both during normal development and in oncogenesis. As transcription factors, MYC family members are difficult to target with small-molecule inhibitors, but the acetyltransferase domain and the bromodomain in GCN5 might provide alternative targets for disruption of MYC-driven functions. GCN5 is part of two distinct multiprotein histone-modifying complexes, SAGA and ATAC. This review summarizes key findings on the roles of SAGA and ATAC in embryo development and in cancer to better understand the functional relationships of these complexes with MYC family members, as well as their future potential as therapeutic targets.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:80

Enthalten in:

Cancer research - 80(2020), 10 vom: 15. Mai, Seite 1905-1911

Sprache:

Englisch

Beteiligte Personen:

Mustachio, Lisa Maria [VerfasserIn]
Roszik, Jason [VerfasserIn]
Farria, Aimee [VerfasserIn]
Dent, Sharon Y R [VerfasserIn]

Links:

Volltext

Themen:

EC 2.3.1.48
Journal Article
P300-CBP Transcription Factors
P300-CBP-associated factor
Proto-Oncogene Proteins c-myc
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Review
Transcription Factors

Anmerkungen:

Date Completed 26.10.2020

Date Revised 15.11.2020

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1158/0008-5472.CAN-19-3652

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM306869004